Insights from 2024 ESMO GI Annual Meeting
ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - 3-Year Analysis From the TOPAZ-1 Study
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Do-Youn Oh
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Do-Youn Oh
Login to view comments.
Click here to Login
